Blue Water Biotech
A Nasdaq commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for oncology.
Launch date
Employees
Market cap
CAD6.6m
Enterprise valuation
CAD14m (Public information from Dec 2023)
Share price
$0.166 BWV
Cincinnati Ohio (HQ)
Financials
Estimates*
USD | 2019 | 2020 | 2021 | 2022 | 2024 |
---|---|---|---|---|---|
Revenues | - | - | - | - | <1m |
EBITDA | (<1m) | (1.6m) | (3.4m) | (13.5m) | - |
Profit | (<1m) | (1.6m) | (3.4m) | (13.4m) | - |
R&D budget | <1m | <1m | 1.3m | 4.1m | - |
Related Content
Recent News about Blue Water Biotech
EditInvestments by Blue Water Biotech
EditACQUISITION by Onconetix Dec 2023